Seeking Alpha

Depomed beats by $0.92, beats on revenue

  • Depomed (DEPO): Q4 EPS of $0.72 beats by by $0.92.
  • Revenue of $40.61M (+52.7% Y/Y) beats by $21.55M.
  • Press Release

Check out Seeking Alpha’s new Earnings Center »

This was corrected on 03/13/2014 at 03:05 AM.
Comments (4)
  • Jason Napodano, CFA
    , contributor
    Comments (981) | Send Message
     
    DEPO reported +$0.72 per share, crushing expectations. I think this is a mistake???
    Looks Seeking-Alpha put -$0.72 instead of +$0.72.
    Jason
    12 Mar 2014, 09:59 PM Reply Like
  • bigbadbubble
    , contributor
    Comments (2) | Send Message
     
    Depo Q4 EPS is +.72 not -.72. Whats this?
    12 Mar 2014, 10:08 PM Reply Like
  • bigbadbubble
    , contributor
    Comments (2) | Send Message
     
    Depo Q4 EPS is +.72, not -.72. Whats with this???
    12 Mar 2014, 10:08 PM Reply Like
  • purplerain
    , contributor
    Comments (41) | Send Message
     
    can you explain all this in terms that I can understand?
    13 Mar 2014, 09:44 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs